-
INmune Bio's INKmune Hits End Points in mCR Prostate Cancer Trial
08 Aug 2025 05:02 GMT
… of metastatic castration-resistant prostate cancer (mCRPC), has met … the therapy in future clinical trials.
“INKmune was safe … a randomized phase 2b clinical trial that will evaluate … with metastatic castration-resistant prostate cancer. News release. INmune …
-
Adding radiation therapy to ADT extends PFS in oligometastatic prostate cancer
07 Aug 2025 00:08 GMT
… 174 patients through clinical trial sites across the … state [androgen deprivation-resistant prostate cancer,]” the authors wrote. … biomarkers and future clinical trials combining MDT + ADT … Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase …
-
Exploring Recent Developments in the Treatment of Prostate Cancer
07 Aug 2025 00:08 GMT
Please enable Javascript
1:56-4:02 - Importance of trial design in therapy selection
4:02-8:09 - Benefits of cooperative trials and comparison of trial end points
8:09-12:10 - Applicability of trial inclusion criteria in daily practice
12:10-13:17 - Moving …
-
Neuroendocrine Prostate Cancer Market Forecast Shows Accelerated CAGR Due to Diagnostic Advancements and Research Investment | DelveInsight
04 Aug 2025 17:00 GMT
… IIa clinical trial, … aggressive prostate cancers and … prostate cancer epidemiology trends @ Neuroendocrine Prostate Cancer Treatment Algorithm
Neuroendocrine Prostate Cancer … prostate cancer drugs in development @ Neuroendocrine Prostate Cancer Clinical Trials …
-
Consensus Guidelines Needed to Further Optimize PARP Inhibition, Molecular Imaging, and ARPI Use in Prostate Cancer Management
04 Aug 2025 13:51 GMT
… in advanced prostate cancer; and ongoing clinical trials aiming … metastatic castration-sensitive prostate cancer (mCSPC)?
Treatment … metastatic hormone-sensitive prostate cancer (mHSPC)?
Patient … metastatic hormone-sensitive prostate cancer setting.
Candidates …
-
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
04 Aug 2025 12:00 GMT
… metastatic castration-resistant prostate cancer (mCRPC) has … metastatic castration-resistance prostate cancer. The third program … clinical trials, are still in clinical trials or are preparing to start clinical trials … drug for clinical trials; the availability …
-
Atavistik Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ATV-1601 in Patients with AKT1 E17K-mutant Solid Tumors
04 Aug 2025 11:00 GMT
… prevalence in breast, endometrial, and prostate cancers. In addition, early evidence indicates … currently conducting a Phase 1 clinical trial of ATV-1601, a selective …
-
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
08 Aug 2025 11:04 GMT
… metastatic castration-resistant prostate cancer, or pancreatic adenocarcinoma … label Phase 1 clinical trial designed to investigate … clinical trials does not ensure that later clinical trials … studies or clinical trials; clinical trial site activation …
-
War Causes Cancer
08 Aug 2025 08:50 GMT
… had a higher risk of prostate cancer, which correlated with length of … driven cancer treatment strategies and clinical trials.
The survivor identity that arose …
-
Colorectal cancer diagnoses soar among younger adults for one key reason
08 Aug 2025 10:52 GMT
… brain cancer diagnosis through a clinical trial for a stem cell treatment … increase from 2021 to 2022.
PROSTATE CANCER SCREENING AFTER 70: EXPERTS QUESTION …
About
© 1995-2025